Revenue of $836.4M in 2026Q3 was essentially all fee-driven (102.8% of total) while the efficiency ratio of 94.1% and a -61.2% year-over-year EPS decline point to severe margin compression.
Lazard Inc (LAZ) annual income statement — 22-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 |
|---|
| Net Interest Income | -58.22M | -49.13M | -34.46M | -35.65M | -52.06M | -75.22M | -74.97M | -64.4M | -45.35M | -46.37M | -45.06M | -45.87M | -57.21M | -74.68M | -75.56M | -75.52M | -76.74M | -78.66M | -57.95M | -47.17M | -59.18M | -43.75M | -11.88M |
| NII Growth % | -149.17% | -42.55% | 3.33% | 31.53% | 30.78% | -0.34% | -16.41% | -41.99% | 2.2% | -2.92% | 1.77% | 19.82% | 23.39% | 1.17% | -0.05% | 1.6% | 2.43% | -35.72% | -22.87% | 20.3% | -35.28% | -268.15% | - |
| Net Interest Margin % | -1.28% | -0.99% | -0.72% | -0.77% | -0.89% | -1.05% | -1.26% | -1.14% | -0.91% | -0.94% | -0.99% | -1.02% | -1.71% | -2.48% | -2.53% | -2.45% | -2.24% | -2.5% | -2.02% | -1.23% | -1.84% | -2.29% | -0.34% |
| Interest Income | 31.99M | 38.49M | 53.6M | 42.02M | 29.46M | 5.55M | 5.67M | 15.79M | 13.13M | 7.14M | 5.23M | 5.29M | 5.36M | 4.71M | 6.01M | 14.61M | 20.97M | 29.23M | 81.94M | 89.94M | 45.07M | 34.62M | 27.67M |
| Interest Expense | 90.21M | 87.62M | 88.07M | 77.67M | 81.52M | 80.77M | 80.63M | 80.19M | 58.48M | 53.52M | 50.29M | 51.16M | 62.57M | 79.38M | 81.56M | 90.13M | 97.71M | 107.89M | 139.9M | 137.11M | 104.25M | 78.36M | 39.55M |
| Loan Loss Provision | 1.19B | 2.09B | 1.92B | 1.87B | 1.57B | 1.82B | 1.47B | 1.48B | 1.46B | 1.46B | 1.29B | 1.27B | 1.25B | 1.2B | 1.27B | 1.08B | 1.1B | -107.89M | -139.9M | -137.11M | -104.25M | -78.36M | -39.55M |
| Non-Interest Income | 3.33B | 3.15B | 3.03B | 2.51B | 2.8B | 3.26B | 2.64B | 2.64B | 2.86B | 2.68B | 2.37B | 2.39B | 2.35B | 2.06B | 1.98B | 1.89B | 1.96B | 1.5B | 1.48B | 1.83B | 1.45B | 1.27B | 1.07B |
| Non-Interest Income % | 101.78% | 101.59% | 101.15% | 101.44% | 101.9% | 102.36% | 102.93% | 102.5% | 101.61% | 101.76% | 101.94% | 101.95% | 102.49% | 103.77% | 103.96% | 104.16% | 104.07% | 105.53% | 104.09% | 102.65% | 104.26% | 103.58% | 101.13% |
| Total Net Revenue | 3.27B | 3.1B | 3B | 2.47B | 2.74B | 3.19B | 2.56B | 2.57B | 2.81B | 2.64B | 2.33B | 2.35B | 2.3B | 1.98B | 1.91B | 1.81B | 1.88B | 1.42B | 1.42B | 1.78B | 1.39B | 1.22B | 1.06B |
| Revenue Growth % | 10.25% | 3.36% | 21.22% | -9.86% | -13.91% | 24.49% | -0.41% | -8.61% | 6.68% | 13.27% | -0.86% | 2.32% | 15.88% | 3.89% | 5.04% | -3.69% | 32.46% | 0.38% | -20.4% | 28.16% | 13.59% | 15.9% | - |
| Non-Interest Expense | 1.76B | 597.78M | 696.62M | 685.09M | 652.34M | 648.56M | 588.28M | 695.08M | 676.21M | 352.37M | 520.43M | 1.1B | 524.59M | 564.69M | 512.99M | 500.58M | 544.29M | 1.53B | 1.56B | 1.92B | 1.49B | 1.3B | 1.09B |
| Efficiency Ratio | 53.8% | 19.29% | 23.23% | 27.7% | 23.77% | 20.35% | 22.98% | 27.04% | 24.04% | 13.36% | 22.35% | 46.69% | 22.86% | 28.51% | 26.91% | 27.58% | 28.88% | 107.58% | 109.87% | 107.7% | 107.5% | 106.41% | 103.75% |
| Operating Income | 319.81M | 415.32M | 386.47M | -79.96M | 516.85M | 723.85M | 502.14M | 392.7M | 680.77M | 825.45M | 517.46M | -16.62M | 519.47M | 216.81M | 123.89M | 235.5M | 243.65M | -182.23M | 25.14M | 418.3M | 327.21M | 342.36M | 288.21M |
| Operating Margin % | 9.78% | 13.4% | 12.89% | -3.23% | 18.83% | 22.71% | 19.61% | 15.27% | 24.2% | 31.3% | 22.23% | -0.71% | 22.63% | 10.95% | 6.5% | 12.98% | 12.93% | -12.81% | 1.77% | 23.49% | 23.55% | 27.99% | 27.31% |
| Operating Income Growth % | - | 7.46% | 583.35% | -115.47% | -28.6% | 44.15% | 27.87% | -42.32% | -17.53% | 59.52% | 3213.48% | -103.2% | 139.6% | 75.01% | -47.39% | -3.35% | 233.7% | -824.88% | -93.99% | 27.84% | -4.43% | 18.79% | - |
| Pretax Income | 266.88M | 327.6M | 386.47M | -79.96M | 516.85M | 723.85M | 502.14M | 392.7M | 680.77M | 825.45M | 517.46M | -16.62M | 519.47M | 216.81M | 123.89M | 235.5M | 243.65M | -182.23M | -239K | 235.66M | 161.8M | 220.05M | 357.76M |
| Pretax Margin % | 8.16% | 10.57% | 12.89% | -3.23% | 18.83% | 22.71% | 19.61% | 15.27% | 24.2% | 31.3% | 22.23% | -0.71% | 22.63% | 10.95% | 6.5% | 12.98% | 12.93% | -12.81% | -0.02% | 13.23% | 11.65% | 17.99% | 33.9% |
| Income Tax | 68.7M | 76.58M | 99.76M | -22.65M | 124.36M | 181.3M | 99.45M | 94.98M | 148.32M | 565.6M | 123.77M | -1.01B | 85.4M | 51.69M | 31.1M | 44.94M | 49.23M | 6.01M | 25.38M | 80.62M | 68.81M | 58.98M | 28.38M |
| Effective Tax Rate % | 25.74% | 23.38% | 25.81% | 28.33% | 24.06% | 25.05% | 19.8% | 24.19% | 21.79% | 68.52% | 23.92% | 6074.32% | 16.44% | 23.84% | 25.1% | 19.08% | 20.2% | -3.3% | -10618.83% | 34.21% | 42.53% | 26.81% | 7.93% |
| Net Income | 184.75M | 236.83M | 279.91M | -75.48M | 357.52M | 528.06M | 402.46M | 286.5M | 527.13M | 253.58M | 387.7M | 986.37M | 427.28M | 160.21M | 84.31M | 174.92M | 174.98M | -130.24M | 3.14M | 155.04M | 92.98M | 143.49M | 246.97M |
| Net Margin % | 5.65% | 7.64% | 9.34% | -3.05% | 13.03% | 16.57% | 15.72% | 11.14% | 18.74% | 9.62% | 16.65% | 42% | 18.62% | 8.09% | 4.42% | 9.64% | 9.29% | -9.16% | 0.22% | 8.71% | 6.69% | 11.73% | 23.4% |
| Net Income Growth % | -32.4% | -15.39% | 470.85% | -121.11% | -32.3% | 31.21% | 40.48% | -45.65% | 107.87% | -34.59% | -60.69% | 130.85% | 166.69% | 90.03% | -51.8% | -0.04% | 234.35% | -4250.48% | -97.98% | 66.74% | -35.2% | -41.9% | - |
| Net Income (Continuing) | 198.18M | 251.02M | 286.71M | -57.31M | 392.48M | 542.54M | 402.69M | 297.72M | 532.45M | 259.85M | 393.69M | 992.93M | 434.06M | 165.11M | 92.78M | 190.56M | 194.42M | -188.25M | -239K | 337.68M | 258.4M | 283.38M | 329.39M |
| EPS (Diluted) | 1.72 | 2.17 | 2.68 | -0.90 | 3.51 | 4.63 | 3.54 | 2.44 | 4.06 | 1.91 | 2.92 | 7.40 | 3.20 | 1.21 | 0.65 | 1.36 | 1.36 | -1.66 | 0.02 | 2.79 | 2.31 | 3.82 | 6.59 |
| EPS Growth % | -34.71% | -19.03% | 397.78% | -125.64% | -24.19% | 30.79% | 45.08% | -39.9% | 112.57% | -34.59% | -60.54% | 131.25% | 164.46% | 86.15% | -52.21% | 0% | 181.93% | -6847.97% | -99.12% | 20.78% | -39.53% | -42.03% | - |
| EPS (Basic) | - | 2.43 | 2.93 | -0.90 | 3.68 | 4.90 | 3.69 | 2.57 | 4.43 | 2.09 | 3.11 | 7.87 | 3.49 | 1.33 | 0.72 | 1.48 | 1.68 | -1.66 | 0.05 | 3.04 | 2.42 | 3.83 | 6.59 |
| Diluted Shares Outstanding | 107.28M | 106.34M | 102.39M | 88.99M | 101M | 113.67M | 113.48M | 116.08M | 129.77M | 132.48M | 132.63M | 133.25M | 133.81M | 133.74M | 129.33M | 137.63M | 138.47M | 78.31M | 127.35M | 62.21M | 44.17M | 37.56M | 37.5M |
Quick answers to the most common questions about buying LAZ stock.
For fiscal year 2025, Lazard Inc (LAZ) reported total revenue of $3.10B. This represents a 193.7% increase compared to $1.06B in 2004.
Lazard Inc (LAZ) is profitable, generating $236.8M in net income for the fiscal year ending 2025 with a net profit margin of 7.6%.
Lazard Inc (LAZ) reported an operating income of $415.3M, resulting in an operating profit margin of 13.4%. This margin reflects the operational efficiency of the business before interest and taxes.
Lazard Inc (LAZ) generated $1.01B in gross profit for the year, representing a gross profit margin of 32.7%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Fee income cyclical dependency
Metrics are mathematically derived from official filings.
Persistent Net Interest Income Drag
Net interest income has deteriorated from -$7.5M in 2024Q3 to -$22.2M in 2026Q3, with the deficit widening materially in recent quarters. According to recent SEC filings, this structural drag reflects funding cost dynamics that have worsened rather than stabilized, expanding the negative contribution by approximately 196% over the eight-quarter window.
The trajectory of NII suggests that Lazard's balance sheet is functioning as a net funding cost center rather than a yield-generating engine. The acceleration from -$15.0M in 2025Q3 to -$22.2M in 2026Q3 implies that the firm's cash management and financing arrangements have become progressively more expensive, possibly tied to the Debt/Equity ratio of 2.61 noted in recent context. While the absolute magnitude is modest relative to total revenue, the consistent negative sign and worsening slope indicate this is not a transient item but a structural feature that will continue to erode pre-provision earnings unless management rebalances its liquidity posture.
Fee Income Dominance Exposes Cycle Risk
Non-interest income reached 102.8% of total revenue in 2026Q3, up from 101.0% in 2024Q3, as reported in Lazard's financial statements. This concentration confirms that advisory and asset management fees constitute essentially the entire earnings base, leaving virtually no offsetting income stream when transaction volumes decline.
The fee-to-revenue ratio exceeding 100% is a direct mathematical consequence of the negative NII line, but it also highlights a fundamental fragility in the business model. Unlike diversified banks that can rotate earnings toward net interest income when capital markets slow, Lazard's income statement is almost wholly exposed to the M&A and restructuring cycle. Investors should note that the recent uptick in this ratio to 102.8% coincides with a period of modest revenue growth of 3.4% year-over-year, suggesting the fee base is not expanding fast enough to build a meaningful cushion against a European deal slowdown, which remains an unresolved risk for the firm.
Operating Leverage Deteriorates Sharply
The efficiency ratio surged to 94.1% in 2026Q3 from 23.4% in 2026Q1, reflecting a near-complete loss of operating leverage in the most recent quarter. Based on Lazard's reported figures, this swing represents the worst efficiency reading in the ten-quarter series and appears to reflect cost absorption that has significantly outpaced the modest revenue recovery.
Operating income of $77.0M in 2026Q3 on $836.4M of revenue implies a pre-provision operating margin of roughly 9%, which is starkly below the 16-20% range observed in earlier quarters of the series. Given that Lazard's compensation ratio is the primary lever for margin stability, the compression suggests the firm may be carrying elevated personnel costs associated with the Lazard 2030 reinvestment plan without yet seeing the corresponding revenue inflection. The contrast with peers like Houlihan Lokey at a 23.6% operating margin and Evercore at 20.5% underscores that Lazard's earnings conversion is currently lagging the boutique peer set, and investors should monitor whether this reflects a temporary investment phase or a structural shift in the cost base.
Provision Swings Obscure Underlying Earnings
Loan loss provisions ranged from $0 in 2026Q2 to $703.1M in 2025Q4, introducing extreme volatility into operating income comparability across periods. As reported in financial statements, these wide swings make it difficult to isolate underlying earnings momentum, and the absence of any provision in 2026Q2 alongside depressed operating income warrants further investigation.
The provision line, which has fluctuated between zero and over $700M within a twelve-month span, appears to be functioning as a significant swing factor in reported profitability rather than a stable reflection of credit risk trends. This is unusual for a firm of Lazard's advisory-centric profile and suggests either material mark-to-market adjustments in a securities or lending book, or idiosyncratic items that are not being normalized in headline EPS. Analysts should be cautious about extrapolating from any single quarter's operating income without first understanding the drivers behind these provision swings, as the Q1 2026 operating income of $104.6M may not be directly comparable to the Q2 2026 figure of $37.6M given the zero-provision anomaly.
2026Q2 Represents a Structural Inflection
2026Q2 produced EPS of $0.04 on net income of $4.8M, the lowest in the ten-quarter series, driven by a collapse in operating income to $37.6M despite revenue of $830.2M. According to recent SEC filings, this quarter marks a clear earnings inflection point where the combination of elevated costs and zero provisions produced a de facto loss-making quarter.
The 2026Q2 result is the single most important period in Lazard's recent income statement because it demonstrates the firm's capacity to generate minimal net income even when top-line revenue is near its historical peak of approximately $830M. The recovery to $0.26 EPS in 2026Q3, while directionally positive, remains well below the $0.67 recorded in 2025Q3 and the $1.02 in 2024Q3, suggesting the earnings recovery is partial rather than complete. Given that management did not issue formal forward guidance alongside the Q3 report, the durability of this rebound remains uncertain, and investors should treat the Q2 trough as a stress marker that reveals how sensitive Lazard's bottom line is to even modest cost overruns when fee volumes plateau.
Earnings Quality Faces Structural Pressure
Lazard's earnings profile combines a worsening NII deficit of -$22.2M, fee income at 102.8% of revenue, and an efficiency ratio of 94.1%, collectively suggesting a business under significant margin pressure. As reported in financial statements, the firm's Debt/Equity ratio of 2.61 alongside 3.4% revenue growth raises questions about whether current earnings reflect durable franchise strength or temporary cost management.
The strongest analytical challenge to Lazard's earnings quality centers on the convergence of three unfavorable trends: a structurally negative and worsening NII line, near-total dependence on cyclical advisory fees, and a sharp deterioration in operating leverage during 2026Q2 and Q3. While the firm's sovereign advisory franchise may provide a counter-cyclical revenue floor, the reported data does not yet demonstrate that this buffer is sufficient to offset compression in core M&A fee income, particularly given the unresolved European exposure risk flagged in recent context. Additionally, the gap between Lazard's current operating margin and peer benchmarks at Evercore, PJT, and Moelis suggests the market may be pricing in a recovery in advisory volumes that has not yet materialized in the reported figures, and any further deterioration in the provision or cost lines could amplify downside to consensus estimates.